Get our Free Patent Expiration, Litigation, and Drug Price Updates

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
US Department of Justice

Generated: April 22, 2019

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 050536

« Back to Dashboard

NDA 050536 describes ERYC, which is a drug marketed by Mayne Pharma, Parke Davis, Warner Chilcott Llc, Hospira, and Johnson And Johnson, and is included in seven NDAs. It is available from one supplier. Additional details are available on the ERYC profile page.

The generic ingredient in ERYC is erythromycin. There are one hundred and three drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the erythromycin profile page.
Summary for 050536
Applicant:Mayne Pharma
Formulation / Manufacturing:see details
Medical Subject Heading (MeSH) Categories for 050536
Suppliers and Packaging for NDA: 050536
Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ERYC erythromycin CAPSULE, DELAYED REL PELLETS;ORAL 050536 NDA AUTHORIZED GENERIC Mayne Pharma Inc. 68308-250 68308-250-10 100 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE, PLASTIC (68308-250-10)

Profile for product number 001

Active Rx/OTC/Discontinued:RXDosage:CAPSULE, DELAYED REL PELLETS;ORALStrength250MG
Approval Date:Approved Prior to Jan 1, 1982TE:ABRLD:Yes

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Express Scripts
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.